Univec(OTC) UNVC

Univec, Inc. is a medical device firm focused on developing, licensing, and selling innovative products in the healthcare sector. The company specializes in auto-disable and safety syringes, catering to both domestic and international markets.

Products and Services

• Auto-disable syringes for precise medication dispensing
• Sliding sheath syringes to prevent needlestick injuries
• Bifurcated needle safety syringes for smallpox vaccinations

Growth Outlook

• Increasing demand for safety syringes in healthcare facilities
• Expansion into international markets, particularly in developing countries
• Potential partnerships with pharmaceutical companies for drug sample tracking

Financial Highlights

• Q2 2026 revenue of $21,025, a 9% increase from Q1 2026
• Trailing twelve months (TTM) gross profit margin of 16.1%
• Operating expenses of $311,541 in Q2 2026, indicating cost management efforts

Univec, Inc. operates in the medical device industry, primarily focusing on safety syringes that address critical healthcare needs. The company has shown a positive trend in revenue growth, with a notable increase in Q2 2026 compared to the previous quarter. This growth reflects the rising demand for safety devices in healthcare settings, driven by heightened awareness of needlestick injuries and the importance of patient safety. The company's strategic focus on expanding its product offerings and entering new markets positions it well for future growth. Collaborations with pharmaceutical companies could further enhance its market presence and operational efficiency. Financially, while the company has faced challenges, the gross profit margin indicates potential for profitability as operational efficiencies improve. Investors may find Univec, Inc. an intriguing opportunity within the healthcare sector, particularly given its commitment to innovation and safety in medical devices.